Congjun Xu

497 total citations
24 papers, 386 citations indexed

About

Congjun Xu is a scholar working on Molecular Biology, Organic Chemistry and Biomedical Engineering. According to data from OpenAlex, Congjun Xu has authored 24 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Biomedical Engineering. Recurrent topics in Congjun Xu's work include Nanoplatforms for cancer theranostics (7 papers), Marine Sponges and Natural Products (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Congjun Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Marine Sponges and Natural Products (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Congjun Xu collaborates with scholars based in China. Congjun Xu's co-authors include Chunshun Zhao, Yanjuan Huang, Yifeng Shen, Gaofei Wei, Liang‐Feng Huang, Xiaoyu Xu, Zeqian Huang, Zishan Zeng, Yali Jiang and Zilin Guan and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and Free Radical Biology and Medicine.

In The Last Decade

Congjun Xu

22 papers receiving 382 citations

Peers

Countries citing papers authored by Congjun Xu

Since Specialization

Citations

This map shows the geographic impact of Congjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congjun Xu more than expected).

Fields of papers citing papers by Congjun Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congjun Xu. The network helps show where Congjun Xu may publish in the future.

Co-authorship network of co-authors of Congjun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Congjun Xu. A scholar is included among the top collaborators of Congjun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congjun Xu. Congjun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of novel rigid STING PROTAC degraders as potential therapeutics for acute kidney injury 2025 ·European Journal of Medicinal Chemistry ·Rui Ma, (unknown), (unknown), (unknown), Yuqi Fan, Zichao Yang, (unknown), Feifei Liu, Zhong‐Ping Jiang, Yong Rao, Ling Huang, Congjun Xu, Jianjun Chen, Jin Liu	2
2	Discovery of novel 2,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridine-7-one derivatives as PDE2 inhibitors with Alzheimer's disease therapeutic potential 2025 ·European Journal of Medicinal Chemistry ·Fan Yang, Qi Guo, (unknown), Wei Wang, Xinyi Chen, Shuting Zhang, (unknown), (unknown), Zhilun Jiao, Qin Wang, (unknown), Yi‐You Huang, Yajing Liu, Congjun Xu, Ling Huang	0
3	Discovery of structurally intriguing diterpenoids as anti-neuroinflammatory agents from mangrove plant Excoecaria agallocha L. via inhibiting macrophage polarization and inflammasome 2025 ·Phytochemistry ·Junyi Li, (unknown), Tingting Fu, Fei‐Fei Liu, Jin Liu, Congjun Xu, (unknown), Yong Rao, Zhongping Jiang, Ling Huang	1
4	Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases 2025 ·Journal of Medicinal Chemistry ·Yuqi Fan, Rui Ma, (unknown), (unknown), Yichang Ren, (unknown), Chen‐Yu Zhang, Feifei Liu, Zhongping Jiang, Yong Rao, Congjun Xu, Ling Huang, Jianjun Chen, Jin Liu	0
5	Eutypetides A—E, Structurally Intriguing Polyketides Formed by Intramolecular [4+2] Cycloaddition from Marine‐Derived Fungus Eutypella sp. F0219 2024 ·Chinese Journal of Chemistry ·Zhongping Jiang, Mengting Chen, X.‐D. Xiang, Congjun Xu, Yong Rao, Hongzhi Du, Wan‐Shan Li, Ling Huang	3
6	Marine fungus Aspergillus c1. sp metabolite activates the HSF1/PGC-1α axis, inducing a thermogenic program for treating obesity 2024 ·Frontiers in Pharmacology ·Yong Rao, Rui Su, Chenyan Wu, Guanyu Yang, (unknown), Junjie Wu, (unknown), Jin Liu, Zhongping Jiang, Congjun Xu, Ling Huang	2
7	Ent-eudesmane sesquiterpenoids with anti-neuroinflammatory activity from the marine-derived fungus Eutypella sp. F0219 2024 ·Phytochemistry ·Zhongping Jiang, Rui Su, Mengting Chen, Junyi Li, Hanyu Chen, (unknown), Fei‐Fei Liu, Jin Liu, Congjun Xu, Wan‐Shan Li, Yong Rao, Ling Huang	8
8	A GSH-responsive oxidative stress nanoamplifier for self-augmented chemo/chemodynamic therapy to reverse cisplatin resistance 2024 ·Acta Biomaterialia ·Yanjuan Huang, (unknown), Congjun Xu, (unknown), Meixu Chen, (unknown), (unknown), Yan Xiao, Chunshun Zhao	1
9	Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunction 2024 ·Pharmacological Research ·Rui Su, Huiling Fu, (unknown), Chenyan Wu, Guanyu Yang, Junjie Wu, Wenjie Cao, Jin Liu, Zhongping Jiang, Congjun Xu, Yong Rao, Ling Huang	6
10	Natural linoleic acid from marine fungus Eutypella sp. F0219 blocks KEAP1/NRF2 interaction and ameliorates MASLD by targeting FABP4 2024 ·Free Radical Biology and Medicine ·Chenyan Wu, Yue Chen, Mengting Chen, Tingting Fu, Jin Liu, Fei‐Fei Liu, Congjun Xu, Wan‐Shan Li, (unknown), Zhong‐Ping Jiang, Yong Rao, Ling Huang	4
11	Identification of a natural PLA2 inhibitor from the marine fungus Aspergillus sp. c1 for MAFLD treatment that suppressed lipotoxicity by inhibiting the IRE-1α/XBP-1s axis and JNK signaling 2023 ·Acta Pharmaceutica Sinica B ·Yong Rao, Rui Su, Chenyan Wu, Xingxing Chai, (unknown), (unknown), Junjie Wu, Tingting Fu, Zhongping Jiang, Zhi‐Kai Guo, Congjun Xu, Ling Huang	14
12	Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy 2022 ·Biomaterials ·Jie Chen, (unknown), Yanjuan Huang, Congjun Xu, Zishan Zeng, Ting Shan, Zilin Guan, Xiaoyu Xu, Zeqian Huang, Chunshun Zhao	43
13	Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction 2021 ·Journal of Medicinal Chemistry ·Mingze Qin, Yangyang Meng, (unknown), Lei Liu, Haotian Zhang, Simeng Wang, Chunyang Liu, Xia Wu, Di Wu, Ye Tian, Yunlei Hou, Yanfang Zhao, Yajing Liu, Congjun Xu, Lihui Wang	46
14	Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibition 2021 ·International Journal of Pharmaceutics ·Congjun Xu, (unknown), (unknown), Tao Zhang, Zilin Guan, Jie Chen, (unknown), Xiaoyu Xu, Yanjuan Huang, Zeqian Huang, Chunshun Zhao	7
15	Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer 2021 ·Journal of Medicinal Chemistry ·Congjun Xu, (unknown), Hongbin Wang, (unknown), Tao Zhang, Zilin Guan, (unknown), Meixu Chen, (unknown), Yuanfeng He, Yuqi Gao, Chunshun Zhao	40
16	Phototriggered Self‐Adaptive Functionalized MOC‐Based Drug Delivery Platform Promises High Antitumor Efficacy 2021 ·Advanced Healthcare Materials ·Yifeng Shen, Congjun Xu, Jie Chen, Zilin Guan, Yanjuan Huang, Zishan Zeng, Xiaoyu Xu, (unknown), Chunshun Zhao	6
17	Design, synthesis and biological evaluation of new Axl kinase inhibitors containing 1,3,4-oxadiazole acetamide moiety as novel linker 2019 ·European Journal of Medicinal Chemistry ·Congjun Xu, Yufei Han, (unknown), Ruxin Wang, Ming Yue, (unknown), Xiaofan Li, Yanfang Zhao, Ping Gong	20
18	Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor 2019 ·Theranostics ·Zeqian Huang, Gaofei Wei, Zishan Zeng, Yanjuan Huang, Liang‐Feng Huang, Yifeng Shen, Xiaoqi Sun, Congjun Xu, Chunshun Zhao	66
19	Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors 2017 ·Bioorganic Chemistry ·(unknown), (unknown), Xue Zhang, Guodong Wu, Congjun Xu, Yanfang Zhao, Ping Gong	6
20	Copper(ii)-mediated formation of oxazole-4-carbonitrile from acetophenone and coordinated cyanide anion via a radical coupling 2017 ·RSC Advances ·Congjun Xu, Mingze Qin, Jun Yi, Yanjing Wang, Yanfeng Chen, Qingfu Zhang, Yanfang Zhao, Ping Gong	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact